Remix Therapeutics to Present at Jefferies Healthcare Conference
- Wednesday, June 1, 2022, 7:01
- Finance
- Add a comment
CAMBRIDGE, Mass., June 1, 2022 /PRNewswire/ — Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, today announced that Peter Smith, Ph.D., Co-Founder and Chief…
About the Author
adminasapcorp has written 38951 stories on this site.